Chemical Compound
Dihydroergotamine tartrate; Bis[(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide] (2R,3R)-2,3-dihydroxybutanedioate
CAS Registry Number
5989-77-5
Primary record
Dihydroergotamine tartrate; Bis[(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide] (2R,3R)-2,3-dihydroxybutanedioate
- 库存
- 6,448 克
- 纯度
- 99.3 %
- CAS
- 5989-77-5
化合物标识与属性
- CAS
- 5989-77-5
- PubChem CID
- 3037136
- SMILES
- C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- Canonical SMILES
- CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)[C@H](O)[C@@H](O)C(=O)O
名称与同义词
- Dihydroergotamine tartrate
- Divegal
- Divegal (TN)
- 9,10-Dihydroergotamine tartrate
- dihydroergotamine L-tartrate
- AC1MI2CK
- RefChem:587716
- Dihydroergotamine tartrate (2:1)
- CHEBI:59757
- dihydroergotamine (R,R)-tartrate
- UNII-76F2R89O7X
- EINECS 227-816-1
- 9,10-dihydroergotaminetartrate
- 5989-77-5
- 76F2R89O7X
- 9,10-dihydroergotamine L-tartrate
- DTXSID30859427
- 9,10-dihydroergotamine (R,R)-tartrate
- Dihydroergotamine (+)-tartrate salt
- DIHYDROERGOTAMINE TARTRATE CRYSTALLINE
- NP0042
- CID3037136
- DIHYDROERGOTAMINE TARTRATE [WHO-DD]
- CID 6713918
- C33H37N5O5.1/2C4H6O6
- Ergotamine, dihydro-, tartrate (2:1)(salt)
- LS-64559
- Dihydroergotamine (+)-Tartrate Salt (2:1)
- D07838
- Ergotamine, dihydro-, tartrate (2:1) (salt)
- C33-H37-N5-O5.1/2C4-H6-O6
- Q27126885
- (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;(2R,3R)-2,3-dihydroxybutanedioic acid
- Bis(5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-methylergotaman-3',6',18-trione) (R-(R*,R*))-tartrate
- Bis[(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman] (2R,3R)-2,3-dihydroxybutanedioate
- (2R,3R)-2,3-Dihydroxybutanedioic acid--5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-10alpha-9,10-dihydroergotaman (1/2)
- Bis((10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman) (2R,3R)-2,3-dihydroxybutanedioate
- Bis[5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-methylergotaman-3',6',18-trione] [R-(R*,R*)]-tartrate
- Dihydroergotamine tartrate; Bis[(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide] (2R,3R)-2,3-dihydroxybutanedioate
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'.alpha.,10.alpha.)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (2:1) (salt)
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)